Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Reports 5 Percent Q3 Revenue Uptick

NEW YORK (GenomeWeb News) – Accelrys today reported a 5 percent increase in revenues for its fiscal third quarter as a loss in the prior-year quarter swung to a profit.

For the three months ended Dec. 31, 2008, revenues increased to $20.6 million from $19.6 million for the prior-year period, Accelrys said.

The company posted net income of $1 million, or $.04 per share, compared to a net loss of $1.2 million, or $.05 per share, for the same quarter of the previous year.

Product development costs fell 24 percent to $3.4 million from $4.5 million in the comparable period of 2007; sales and marketing costs fell 8 percent to $8.8 million from $9.6 million; and general and administrative spending dipped 6 percent to $3.2 million from $3.4 million.

The company had cash and marketable securities of $72.5 million as of Dec. 31, 2008.

Todd Johnson, the company's interim president and CEO, acknowledged in a statement that "the global macroeconomic climate may dampen our growth prospects in the near future." However, he noted that the company believes that its "strong balance sheet and market-leading scientific operating platform products position us for long-term success."

Johnson took the reins at Accelrys this month, after the company's previous CEO, Mark Emkjer, resigned.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.